High Atherogenic Risk in Ketosis-Prone Type 2 Diabetic Individuals with Ketosis Episodes: A Cross-Sectional Study.

Authors:
He X; Luo Y; Hao J; Hu R; Yang X and 1 more

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2023

DOI:
10.2147/DMSO.S421203

PMCID:
PMC10561756

PMID:
37818406

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Metab Syndr Obes

Abbreviation: Diabetes Metab Syndr Obes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass a…
Wang Y; Xu Y; Hu T and 5 more (2024) - Transparency Score: 3/6
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
Arshad MS; Alqahtani F; Rasool MF. (2024) - Transparency Score: 4/6
Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.
Guo C; Jiao M; Cui Y and 4 more (2024) - Transparency Score: 3/6
Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.
Bi Y; Yang Y; Yuan X and 4 more (2024) - Transparency Score: 3/6
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.
Wang X; Liu X; Zhao J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare no conflicts of interest in this work."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025